INS and Insulin resistance: However, other blood biomarkers (for example, insulin, homeostasis model of risk assessment-insulin resistance (HOMA-IR), Hemoglobin A1c and C peptide, etc.)should be evaluated to better understand the effects of lycopene on glucose metabolism.